Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

3.19
Delayed Data
As of 4:00pm ET
 -0.005 / -0.16%
Today’s Change
2.55
Today|||52-Week Range
5.83
-15.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$337.3M

Company Description

Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Contact Information

Catalyst Pharmaceuticals, Inc.
355 Alhambra Circle
Coral Gables Florida 33134
P:(305) 420-3200
Investor Relations:

Employees

Shareholders

Other institutional36.54%
Mutual fund holders26.20%
Individual stakeholders15.23%

Top Executives

Patrick J. McEnanyChairman, President & Chief Executive Officer
Steven R. MillerChief Operating & Scientific Officer
Alicia GrandeCFO, Treasurer, Principal Accounting Officer & VP
Gary IngenitoChief Medical Officer
Stanley IyaduraiVice President-Clinical Development